| Bristol-Myers Squibb SA - Camzyos 15 mg, Hartkapseln | | 68477 | | 04 | | Camzyos 15 mg | | Hartkapseln | | C01EB24 | | Mavacamten | | 25.04.2023 | | |
| | Composition | | mavacamtenum 15 mg, silica colloidalis hydrica, mannitolum, hypromellosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (nigrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), ammoniae solutio concentrata, pro capsula corresp. natrium 1.26 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Active Agent | Dose |
|---|
| Mavacamtenum | 15 mg |
| | BAG: Active Agent | Dose |
|---|
| Mavacamtenum | 15 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Hypromellosum | | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Mannitol | | | | Propylenglycol | | | | Silica Colloidalis Hydrica | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 28 | 1250.15 | 1376.05 | B | SL | No |
|
|
